title: The dosimetric effect of mixed-energy IMRT plans for prostate cancer.
abstract: We investigated the effect of mixing high- and low-energy photon beams on the quality of intensity-modulated radiation therapy (IMRT) plans for patients with prostate cancer. Three different plans for each of twenty patients were generated using either 6 MV or 15 MV alone, and both 6 and 15 MV beams. All the planning parameters, goals, and constraints were set to be identical except beam energy. The dose distributions were similar in terms of target coverage, conformity, and homogeneity regardless of beam energy. The V(70Gy) of rectal wall in 6 MV, 15 MV and mixed-energy plans was 16.7%, 17.9%, and 16.3%, respectively, while V(40Gy) was 55.6%, 53.2%, and 50%. The mean dose to femoral heads in 6 MV, 15 MV, and mixed-energy plans were 31.7 Gy, 26.3 Gy, and 26.2 Gy, respectively. The integral dose of 6 MV plans was 7% larger than those of 15 MV or mixed-energy plans. These results indicated that mixed-energy IMRT plans could take advantage of the dosimetric characteristics of low- and high-energy beams. Even though the reduction of dose to the organs at risk may not be clinically relevant, mixing energy in an IMRT plan for deep-seated tumors can improve the overall plan quality.
authors.affiliation: Department of Radiation Applied Life Science, Seoul National University Graduate School, Seoul, Republic of Korea.
authors.forename: Jong Min
authors.initials: JM
authors.lastname: Park
authors.forename: Chang Heon
authors.initials: CH
authors.lastname: Choi
authors.forename: Sung Whan
authors.initials: SW
authors.lastname: Ha
authors.forename: Sung-Joon
authors.initials: SJ
authors.lastname: Ye
mesh_terms: D006801:Humans; D008297:Male; D017785:Photons; D011471:Prostatic Neoplasms / Q000473:pathology / Q000532:radiotherapy*; D011879:Radiotherapy Dosage; D011880:Radiotherapy Planning, Computer-Assisted / Q000379:methods*; D011882:Radiotherapy, High-Energy / Q000379:methods*
references.citation: J Appl Clin Med Phys. 2006 Nov 28;7(4):43-9
references.pmid: 17533352
references.citation: Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):594-601
references.pmid: 16168851
references.citation: Technol Cancer Res Treat. 2007 Apr;6(2):147-9
references.pmid: 17375978
references.citation: Int J Radiat Oncol Biol Phys. 2008 Jul 15;71(4):1028-33
references.pmid: 18280056
references.citation: Am J Clin Oncol. 2011 Feb;34(1):11-5
references.pmid: 20101167
references.citation: Br J Radiol. 2004 May;77(917):377-86
references.pmid: 15121701
references.citation: Int J Radiat Oncol Biol Phys. 1998 Jun 1;41(3):491-500
references.pmid: 9635694
references.citation: Int J Radiat Oncol Biol Phys. 2005 Jul 15;62(4):1195-203
references.pmid: 15990025
references.citation: J Appl Clin Med Phys. 2001 Spring;2(2):59-68
references.pmid: 11604050
references.citation: Med Phys. 1997 Jul;24(7):1107-16
references.pmid: 9243473
references.citation: Int J Radiat Oncol Biol Phys. 1986 Sep;12(9):1551-7
references.pmid: 3093417
references.citation: Technol Cancer Res Treat. 2007 Apr;6(2):139-46
references.pmid: 17375977
references.citation: Int J Radiat Oncol Biol Phys. 2006 May 1;65(1):1-7
references.pmid: 16618572
references.citation: Med Phys. 1997 Feb;24(2):149-60
references.pmid: 9048355
references.citation: Radiother Oncol. 2007 Jan;82(1):63-9
references.pmid: 17182143
references.citation: Int J Radiat Oncol Biol Phys. 2002 Jun 1;53(2):434-42
references.pmid: 12023148
references.citation: J Appl Clin Med Phys. 2007 Sep 17;8(4):14-27
references.pmid: 18449157
references.citation: Med Dosim. 2006 Winter;31(4):249-58
references.pmid: 17134664
references.citation: Acta Oncol. 1999;38(2):179-87
references.pmid: 10227439
references.citation: Int J Radiat Oncol Biol Phys. 1998 Jun 1;41(3):501-10
references.pmid: 9635695
references.citation: Phys Med Biol. 2000 Mar;45(3):685-702
references.pmid: 10730964
references.citation: Med Phys. 2002 Nov;29(11):2526-7
references.pmid: 12462717